| Literature DB >> 32326415 |
André Albuquerque1, Cristina Óvilo2, Yolanda Núñez2, Rita Benítez2, Adrián López-Garcia2, Fabián García2, Maria do Rosário Félix3, Marta Laranjo1, Rui Charneca4, José Manuel Martins5.
Abstract
When compared to modern lean-type breeds, Portuguese local Alentejano (AL) and Bísaro (BI) pig breeds present a high potential for subcutaneous and intramuscular fat (IMF) deposition which contributes for better meat quality. The aim of this work was to explore the genome function to better understand the underlying physiological mechanisms associated with body fat accretion. Dorsal subcutaneous fat samples were collected at slaughter from adult animals (n = 4 for each breed) with ~150 kg body weight. Total RNA was obtained and sequenced for transcriptome analysis using DESeq2. A total of 458 differentially expressed (DE) genes (q-value < 0.05) were identified, with 263 overexpressed in AL and 195 in BI. Key genes involved in de novo fatty acid biosynthesis, elongation and desaturation were upregulated in AL such as ACLY, FASN, ME1, ELOVL6 and SCD. A functional enrichment analysis of the DE genes was performed using Ingenuity Pathway Analysis. Cholesterol synthesis is suggested to be higher in AL via SREBF2, SCAP and PPARG, while lipolytic activity may be more active in BI through GH and AMPK signalling. Increased signalling of CD40 together with the predicted activation of INSIG1 and INSIG2 in BI suggests that this breed is more sensitive to insulin whereas the AL is less sensitive like the Iberian breed.Entities:
Keywords: Alentejano pig; Bísaro pig; Dorsal subcutaneous fat; RNA-seq; differentially expressed genes (DEGs); transcriptome
Year: 2020 PMID: 32326415 PMCID: PMC7231169 DOI: 10.3390/genes11040422
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Linking lipid biosynthesis with carbohydrate metabolism: direction of upregulated genes in the Portuguese local pig breeds.
Gene expression comparison through RNA-seq and Real Time qPCR of the selected genes.
| Genes | RNA-seq | Real Time qPCR | Correlation | |||
|---|---|---|---|---|---|---|
| Log2 FC | q-Value | Log2 FC |
| |||
|
| 0.854 | 0.116 | 1.055 | 0.077 | 0.986 | 7.07 × 10−6 |
|
| 1.853 | 0.005 | 1.601 | 0.068 | 0.864 | 0.006 |
|
| −0.625 | 0.297 | −0.685 | 0.110 | 0.707 | 0.050 |
|
| 1.236 | 0.009 | 0.671 | 0.136 | 0.650 | 0.081 |
|
| 1.691 | 0.002 | 1.359 | 0.100 | 0.920 | 0.001 |
|
| 1.376 | 0.037 | 0.929 | 0.046 | 0.739 | 0.036 |
|
| 2.090 | 8.42 × 10−6 | 1.008 | 0.106 | 0.757 | 0.030 |
|
| −1.959 | 0.037 | −2.660 | 0.001 | 0.820 | 0.013 |
|
| 2.311 | 0.026 | 1.351 | 0.087 | 0.643 | 0.086 |
Causal regulator effects predicted to be activated and inhibited in AL.
| Master Regulator | Participating Regulators | Predicted Activation (AL) | Z-Score | Target Molecules in Dataset | |
|---|---|---|---|---|---|
| INSIG2 | INSIG2 | Inhibited | −2.236 | 3.74 × 10−6 | 5 |
| FLCN | Esrra, FLCN, MTORC1, PPARGC1A | Inhibited | −2.236 | 7.72 × 10−6 | 20 |
| PKIA | CREB1, Pka, PKIA | Inhibited | −2.887 | 1.26 × 10−5 | 12 |
| LRAT | Akt, INSR, JAK2, LRAT, RPE65, STAT5a/b | Inhibited | −3.300 | 3.03 × 10−5 | 18 |
| NRG4 | NRG4 | Inhibited | −2.000 | 3.76 × 10−5 | 4 |
| PDGF BB | PDGF BB | Inhibited | −2.333 | 1.54 × 10−4 | 9 |
| CREB1 | CREB1 | Inhibited | −2.828 | 1.69 × 10−4 | 8 |
| GNAS | GNAS | Inhibited | −2.236 | 1.97 × 10−4 | 5 |
| MFSD2A | MFSD2A | Inhibited | −2.000 | 4.85 × 10−4 | 4 |
| MEF2C | MEF2C | Inhibited | −2.236 | 1.47 × 10−3 | 5 |
| HSP27 | Hsp27 | Inhibited | −2.000 | 1.63 × 10−3 | 4 |
| NDFIP1 | Akt, Jnk, Map3k7, NDFIP1, PTEN, SRC | Activated | 2.449 | 2.31 × 10−6 | 24 |
| NR1D1 | NR1D1 | Activated | 2.236 | 5.36 × 10−6 | 5 |
| NSUN3 | NSUN3 | Activated | 2.000 | 5.61 × 10−6 | 4 |
| ALKBH1 | ALKBH1 | Activated | 2.000 | 5.61 × 10−6 | 4 |
| UCHL3 | Akt, AMPK, FOXO1, GSK3B, INSR, UCHL3 | Activated | 2.449 | 1.05 × 10−5 | 24 |
| MIR-29B-3P (AND OTHER MIRNAS W/SEED AGCACCA) | Akt, ERK, miR-29b-3p (and other miRNAs w/seed AGCACCA), PMP22 | Activated | 2.500 | 1.06 × 10−5 | 16 |
| ARNTL | Akt, ARNTL, CLOCK, NFE2L2 | Activated | 2.200 | 2.85 × 10−5 | 25 |
| IDH1 | IDH1 | Activated | 2.236 | 2.97 × 10−5 | 5 |
| EPCAM | EPCAM | Activated | 2.000 | 3.76 × 10−5 | 4 |
| ATP7B | Akt, ATP7B | Activated | 2.887 | 4.58 × 10−5 | 12 |
| DAP3 | DAP3 | Activated | 2.000 | 5.36 × 10−5 | 4 |
| BACE1 | BACE1, CREB1, Pka | Activated | 2.714 | 7.70 × 10−5 | 11 |
| ATP7B | ATP7B | Activated | 2.236 | 3.98 × 10−4 | 5 |
| MLXIPL | MLXIPL | Activated | 2.000 | 4.02 × 10−4 | 4 |
| SCAP | SCAP | Activated | 2.449 | 4.21 × 10−4 | 6 |
| SREBF2 | SREBF2 | Activated | 2.449 | 6.09 × 10−4 | 6 |
| GHRL | GHRL | Activated | 2.000 | 8.06 × 10−4 | 4 |
| MED1 | MED1 | Activated | 2.449 | 1.00 × 10−3 | 6 |
Figure 2Carbohydrate metabolism, Lipid metabolism and Molecular transport Ingenuity Pathway Analysis (IPA) Network.